HC Wainwright & Co. initiated coverage on Anixa Biosciences with a new price target

4/12/21 6:30:29 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. initiated coverage of Anixa Biosciences with a rating of Buy and set a new price target of $11.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ANIX

Date	Price Target	Rating	Analyst
3/21/2025	$10.00	Buy	Maxim Group
12/23/2022	$8.00	Buy	Chardan Capital Markets